Company intelligence / Profile preview

QUBIS

Belfast, Northern Ireland, United Kingdomqubis.co.uk ↗

Ownership: Private
Development stage: Other

Overview

As an investor/incubator rather than a drug developer, there are no direct clinical results attributable to "QUBIS" as an entity. Several of its spinouts have reached commercial success or advanced clinical stages—for example Fusion Antibodies listed on LSE and others acquired by major industry players like Philips and PerkinElmer.

Therapeutic areas: Other
Modalities: Cell therapyAntibodyNanotherapyDiagnostics tools
Industry: Investors

Partnerships

Queen's University BelfastInnovate UK ICURe programme

Beyond the preview

Go deeper on QUBIS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on QUBIS.

Explore the full profile